Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia

Cefoperazone, a third-generation cephamycin with broad-spectrum antibacterial activity and the ability to permeate bacterial cell membranes, is active against commonly encountered multidrug-resistant pathogens for hospital-acquired pneumonia (HAP) and health care-associated pneumonia (HCAP). To clar...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Liu, Jien-Wei, Chen, Yen-Hsu, Lee, Wen-Sen, Lin, Jung-Chung, Huang, Ching-Tai, Lin, Hsi-Hsun, Liu, Yung-Ching, Chuang, Yin-Ching, Tang, Hung-Jen, Chen, Yao-Shen, Ko, Wen-Chien, Lu, Min-Chi, Wang, Fu-Der
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2019
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6658783/
https://ncbi.nlm.nih.gov/pubmed/31138577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00023-19
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados